Curcuma Extract Enhances Hepatoprotective Action of Silymarin in Experimental Liver Damage Models |
이기명
(아주대학교 의과대학 소화기내과)
함기백 (아주대학교 의과대학 소화기내과) 조성원 (아주대학교 의과대학 소화기내과) 오태영 (동아제약(주) 연구소) 최설민 (동아제약(주) 연구소) 김정훈 (동아제약(주) 연구소) 안병옥 (동아제약(주) 연구소) 권종원 (동아제약(주) 연구소) 김원배 (동아제약(주) 연구소) |
1 | Jia, J. D., Bauer, M., Cho, J. J., Ruehl, M., Milani, S., Boigk, G- Riecken, E. 0. and Schuppan, D. (2001). Antifibrotic effect of silymarm in rat secondary biliary fibrosis is mediated by downregulation of procollagen alphal (1) and TIMP-1.J. Hepatol. 35, 392-398 DOI ScienceOn |
2 | Kawamori, T., Lubet, R., Steele, V. E., Kellofr, G. J., Kaskey, R. B., Rao, C. V. and Reddy, B. S. (1999). Chemopreventive effect of curcumin, a naturally occurring anti inflammatory agcnt, during the promotion/progression stagcs of colon cancer. Cancer Res. 59, 597-601 |
3 | Piper, J. T., Singhal, S. S., Salameh, M. S., Torman, R. T., Awasthi, Y. C. and Awasthi, S. (1998). Mechanisms of anticarcinogenic properties of curcumin: the effect of curcumin on glutathione linked detoxification enzymes in rat liver. Int. J. Biochem. Cell Biol. 30, 445-456 DOI ScienceOn |
4 | Punithavathi, D., Venkatesan, N. and Babu, M. (2000). Curcumin inhibition of bleomycin-induced pulmonaiy fibrosis in rats. Br. J. PharmacoI. 131, 169-172 |
5 | Chuang, S. E., Kuo, M. L., Hsu, C. H., Chen, C. R., Lin, J. K., Lai, G. M., Hsieh, C. Y. and Cbeng, A. L. (2000). Curcumin-containing diet inhibits diethylmtrosamine induced murine hepatocarcinogenesis. Carcinogenesis 21, 331-335 DOI ScienceOn |
6 | Dehmlow, C., Erhard, J. and de Groot, H. (1996). Inhibition of Kupffer cell functions as an explanation for the bepatoprotective properties of silibinin. Hepatology 23, 749-754 DOI |
7 | Ferenci, P., Dragosics, B., Diltrich, H., Frank, H., Benda, L., Lochs, H., Meryn, S., Base, W. and Schneider, B. (1989) Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver.J. Hepatol. 9, 105-113 DOI ScienceOn |
8 | Halim, A. B., el-Ahmady, 0., Hassab-Allah, S., Abdel-Galil, F., Hafez, Y. and Darwish, A. (1997). A Biochemical effect of antioxidatits on lipids and liver function in experi-mentally-induced liver damage. Ann. Clin. Biochem. 34, 656-663 DOI |
9 | Ishii, K., Matama, S., Shibata, H., Okabe, H., Okudaira, M., Nagata, H. and Tsuchiya, M. (1984). Mici-ocirculatory responses to estradiol benzoate in chronic liver damage induced by carbon tetrachlohde in the rat. Gastroenterol. Jpn. 19, 419-423 |
10 | Janbaz, K. H. and Gilani, A. H. (1995). Evaluation of the protective potential of Artemisia maritima extract on acetamninophen- and CCL-induced liver damage. J. Ethnopharmacol. 41, 43-47 |
11 | Mascher H., Kikuta, C. and Weyhenmeyer, R. (1993). Diasteromeric separation of free and conjugated silibinin in plasma by re ersed phase HPLC after specific extraction. J. Liquid Chromatogr. 16, 2777-2789 DOI ScienceOn |
12 | Lin, J. K., Pan, M. H. and Lin-Shiau, S. Y. (2000). Recent studies on the biofunctions and biotransformatioiis of curcumin. Biofactors 13, 153-158 DOI ScienceOn |
13 | Ramsewak, R. S., DeWitt, D. L. and Nair, M. G. (2000). Cytotoxicity, anlioxidant and anti-inflammatory activities of curcumins l-III from Curcuma longa. Phytomedicine 7, 303-308 DOI ScienceOn |
14 | Lowry, O. H., Rosebrough, N. J., Farr, A. L. and Randall, R. J. (1951) Protein measurement with the Folin phenol reagent. J. BioI. Chem. 193, 265-275 |
15 | Miguez, M. P., Anundi, I., Sainz-Pardo, L. A. and Lindros, K. 0. (1994). Hepatoprotective mechanism of silymarin: no evidence for involvement of cytochrome P450 2E1. Chem. Biol. Interact. 91, 51-63 DOI ScienceOn |
16 | Ohkawa, H., Ohishi, N. and Yagi, K. (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95, 351-358 DOI ScienceOn |
17 | Park, E. J., Jeon, C. H., Ko, G., Kim, J. and Sohn, D. H. (2000). Protective effect of curcumin in rat liver injury induced by carbon tetrachloride. J. Pharm. Pharmacol. 52, 437-440 DOI ScienceOn |
18 | Skottova, N. and Krecman, V. (1998). Silymarin as a potential hypocholesterolaemic drug. PhysioI. Res. 47, 1-7 |
19 | Savio, D., Harrasser, P. C. and Basso, G. (1998). Softgel capsule technology as an enhancer device for the absorption of natural principles in humans. A bioavailability cross-over randomised study on silybin. Arzneimittelforschung 48, 1104-1106 |
20 | Schandalik, R., Gatti, G. and Perucca. E. (1992). Pharma-cokinetics of silybin in bile following administration of silipide aiid silymarin in cholecystectomy patients. Arz-neimittelforschung 42, 964-968 |
21 | Salmi, H. A. and Sarna, S. (1982). Effect of silymain on chemical, functional, and morphological alterations of the liver. A double-blind controlled study. Scand. J. Gastro-enterol. 17, 517-521 DOI ScienceOn |